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Triphala Mashi is an ayurvedic formulation that was prepared in our lab. Aqueous and
alcoholic extracts of both Triphala and Triphala Mashi were used, to evaluate antimicrobial
activity. Comparative phytochemical profile of Triphala and Triphala Mashi was done by
preliminary phytochemical screening, total phenolic content and thin layer chromatography
(TLC). Antimicrobial activity includes isolation of pathogens from clinical samples, its
characterization, testing its multiple drug resistance against standard antibiotics and
antimicrobial activity of aqueous and alcoholic extracts of both Triphala and Triphala Mashi
against these organisms by using agar gel diffusion method. Triphala Mashi containing phenolic
compounds, tannins exhibited comparable antimicrobial activity in relation to Triphala against
all the microorganisms tested. It inhibits the dose-dependent growth of Gram-positive and
Gram-negative bacteria. In conclusion, it appears that Triphala Mashi has non-specific
antimicrobial activity.
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Introduction
Current advancements in drug discovery technology and
search for novel chemical diversity have intensified the
efforts for exploring leads from Ayurveda the traditional
system of medicine in India. Many plant extracts have
been used as a source of medicinal agents to cure urinary
tract infections, cervicitis vaginitis, gastrointestinal dis-
orders, respiratory diseases, cutaneous affections, helmin-
tic infections, parasitic protozoan diseases and
inflammatory processes (1).
Although extremely effective, antibiotics are able to
induce resistance in bacteria. For 450 years, bacterial
resistance has been the main factor responsible for the
increase of morbidity, mortality and health care costs of
bacterial infections. This bacterial defense mechanism is
widely present in bacteria (e.g. Pseudomonas, Klebsiella,
Enterobacter, Acinetobacter, Salmonella, Staphylococcus,
Enterococcus and Streptococcus) and became a world
health problem worsened by developments in human,
animal and plant transportation (2).
Triphala is a traditional Ayurvedic herbal formulation
consisting of the dried fruits of three medicinal plants
Terminalia chebula, Terminalia belerica and Phyllanthus
embelica also known as ‘three myrobalan’. Triphala
means ‘three’ (tri) ‘fruits’ (phala) (3).
Triphala is used in Ayurvedic medicine in treating a
variety of conditions and also forms part of many other
Ayurvedic formulations. Conditions for which Triphala is
employed include headache, dyspepsia, constipation, liver
conditions, ascites and leucorrhoea. It is also used as a
blood purifier that can improve the mental faculties and
is posseses anti-inflammatory, analgesic anti-arthritic,
hypoglycaemic and anti-aging properties (4–8).
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properly cited.Phyllanthus embelica contains ascorbic acid (9) astra-
galin–flavonol (10), gallic acid–benzenoid, emblicol,
phyllemblic acid (11), emblicanin A, emblicanin B,
pedunculagin, punigluconin–tannin (12), ellagic acid
coumarin (13). Terminalia chebula contains arjungenin,
arjunglucoside I (14), gallic acid-benzenoid (15), chebulic
acid, ellagic acid–coumarin, corilagin, punicalagin, terch-
ebulin, terflavin A–tannin (16). -Sitosterol, gallic acid,
ellagic acid, ethyl acetate, galloyl glucose and chebulagic
acid have been isolated from fruits of T. belerica (3).
Mashi (Black ash) is obtained, when any natural product
from vegetable or animal sources is heated slowly, at lower
temperature (generally below 450 C). If heating is con-
tinued further at higher temperatures (above 450 C) it
forms Bhasma (White ash). Mashi is an intermediate
product of Bhasma in which unlike Bhasma, both organic
and inorganic constituents are present.
Mashi is a dosage form in which bulk of raw material is
reduced to a greater extent by application of a certain
quantum of energy. As a result of this treatment hidden
chemical constituents become prominent and/or new
chemical moieties are formed which are therapeutically
active. Due to thermal degradation or decomposition
thermo labile constituent are lost. Therapeutically active
organic and inorganic chemical constituents can be
prepared by simple heat treatment in a controlled manner.
The black color indicates high percentage of carbon and
oxides. Non-specific odor and charcoal like taste may be
attributed to oxides, inorganic elements and carbon (17).
Ayurvedic System of Medicine has its long history of
therapeutic potential. Ayurveda is already well accepted
and used since thousand years. Now it is time to give it
modern scientific proof. Most of the drugs used today are
obtained from natural sources or semi synthetic deriva-
tives of natural products as mentioned and used in the
Traditional Systems of Medicine. Thus it is a logical
approach to drug discovery to screen traditional natural
products instead of randomly synthesized chemical
moieties. So we undertook this Triphala Mashi as a
prototype to give it scientific proof. References about
Triphala Mashi were found in Bhaisajyaratnavali and
Bharat Bhaisjya Ratnakar. The objective of the present
investigation was to analyze antimicrobial potential of
Triphala Mashi and also to assay its toxicities.
Material and Methods
Raw Material
Triphala was procured from local markets, Pune,
Maharashtra, India.
Preparation of Triphala Mashi
Triphala Mashi was prepared by heating the Triphala in
closed silica crucibles in a muffle furnace. Triphala was
heated from 30 C to 450 C higher temperature by
continuously increasing temperature to 10 C/min.
Preparation of Triphala and Triphala Mashi Extracts
Aqueous extracts (1:6) of Triphala and Triphala Mashi
were prepared by hot maceration method and ethanolic
extracts (1:6) of both were prepared using soxhlet
apparatus. The extracts were filtered and the solvent
was removed using rotary evaporator. The extracts were
stored in an airtight glass bottle in a refrigerator.
Preliminary Phytochemical Screening (18)
Phytochemical evaluation of aqueous and ethanol extract
of Triphala and Triphala Mashi: A stock solution was
prepared by dissolving 500mg extract in 20ml of solvent
that was subjected to preliminary phytochemical testing
for the detection of major chemical groups.
Antimicrobial Activity using Agar Diffusion Method
We accomplished isolation of pathogens from clinical
samples obtained at the hospital, Pune (India) with
specific diagnosis of the different human pathologies.
They were characterized through microscopic examina-
tion, Gram’s character, and biochemical test profile. They
were analyzed multiple drug resistance against standard
antibiotics and antimicrobial activity with Agar Diffusion
Method of plant extract against the organisms.
Isolation of Pathogens from Clinical Samples
The organisms were isolated from patients who visited
clinical pathology for samples like sputum, wound swab,
urine, pus, semen, bronchial lavage, etc. The standard
method for isolation and identification based on micro-
scopic examination, cultural characteristics and biochem-
ical properties was followed (19). The samples were
collected carefully, avoiding contamination with normal
flora of the body and enriched in selective media and
subjected to identification and characterization.
Characterization (19)
It was based on the microscopic examination, Gram’s
character and biochemical test, profile is presented in
table 1.
Testing Multiple Drug Resistance against Standard
Antibiotics
Isolated cultures were grown overnight in sterile
nutrient broth and their optical density (O.D.) adjusted
to 0.1. This O.D. adjusted culture was spread on
sterile nutrients agar plates. With a sterile forcep the
multi-antibiotic disc was placed on the spreaded plate.
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drug for half an hour. The plates were then incubated at
37 c for 24h. Zone of inhibition around the particular
drug was observed and recorded.
Testing Antimicrobial Activity of Triphala and Triphala
Mashi Extracts (20)
Antimicrobial activity was checked by agar gel diffusion
method. The cultures were grown in nutrient broth and
incubated at 37 C, for 24h. After incubation period is
finished the O.D. of the culture was adjusted to 0.1 with
sterile nutrient broth. The 0.1ml of the culture was
seeded in 25ml molten nutrient agar butts, mixed and
poured into sterile petri plate and allowed to solidify.
The wells were bored with 8mm borer in seeded agar.
Then the particular concentration (50–1500mg/ml) of the
Triphala and Triphala Mashi extract (0.4ml each
containing 50–1500mg/ml) was added in each well.
Soon afterwards the plates were then kept at 10 C for
30min. After it normalized to room temperature plates
were incubated at 37 C for 24h. After incubation period
was finished the zone of inhibition was measured and
recorded.
Acute Oral Toxicity
Acute oral toxicity refers to those adverse effects that
occurred following oral administration of a single dose of
a substance or multiple doses given within 24h. OECD
Guideline No. 425 (Acute Oral Toxicity–Acute Toxic
Class Method) is undertaken as a test procedure to
ascertain the acute oral toxicity, that occurred after
administration of the test substance. The test procedure
described in this OECD guideline is of value in
minimizing the number of animals required to estimate
the acute oral toxicity. In addition to the estimation of
LD50 and confidence intervals, the test allows observation
of signs of toxicity.
Test Report
We worked with six groups of six mice each, of the swiss
albino mice species/strain, sourced from National
Toxicology Center, Pune, of the female sex, weighing
25–30g, maintained in standardized environmental con-
ditions (animal house conditions) with free access to food
and water and with water used as vehicle. We tested
aqueous and alcoholic extracts of Triphala and Triphala
Mashi, in conditions presented subsequently.
Test Conditions
Individual body weights of rats were determined just
before dosing. All extracts were dissolved in water.
No information was available on toxicity of the
substance to be tested. As per AOT 425, initial dose of
175-mg/kg-body weight was administered. Rats were
observed for 48h. Based on the status (alive or died)
of rats during the observation period the next dose of
the test drug is decided as per OECD guidelines 425.
Stopping criteria was met as three consecutive animals
survived at the upper limit (5000mg/kg) or three
consecutive rats died. Oral administration of the drug
solution was carried out using a ‘gavage’. Drug solution
was prepared freshly just before dosing. Dosing volume
was 1ml/100g of body weight, at 9:30am. After
the period of fasting, performed rats were weighed
and then the test substance was adminstered and after
the administration of drug, food was withheld for 1–2h.
Table 1. Microscopic and biochemical profile of clinical isolates
Isolate No. Name of the organism Biochemical tests
Indole Urease Citrate TSI Oxidase Catalase Coagulase
2443 Escherichia Coli (urine) þve þve þve A/G N/A N/A N/A
2438 Klebsiella Pneumoniae (extra ETT) secretion  ve þve þve A/G N/A N/A N/A
2379 Pseudomonas Aeruginosa (Wound swab)  ve þve þve A/G þve þve N/A
2444 Pseudomonas Aeruginosa (semen)  ve  ve þve A/G  ve þve N/A
2378 Escherichia Coli (urine) þve  ve  ve A/G N/A N/A N/A
2401 Staphylococcus aureus (Urine)  ve þve  ve A  ve þve þve
2384 Klebsiella Pneumoniae (Pus from abdominal wound)  ve þve  ve A/G N/A N/A N/A
2381 Staphylococcus aureus (Urine)  ve þve  ve A  ve þve  ve
2445 Staphylococcus aureus (urine)  ve þve  ve A  ve þve  ve
2447 Staphylococcus aureus(urine)  ve þve  ve A  ve þve  ve
N/A, Not Applicable; A/G, Acid and Gas production; A, Acid production; þve, Possitive;  ve, Negative.
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Isolate
No.
Name of
the organism
Amikacin Bactrim Ciprofloxacin Cefotoxime Cefatazidime Cefuroxime Ceftriaxone Furadentin Augmetin Norfloxacin Netromycin Cefaparazone Levofloxacin Epocinin Piperacillin Ofloxacin
2443 Escherichia
Coli (urine)
SS R R R R R S RR R R R R R R
2438 Klebsiella
Pneumoniae
(extra ETT)
secretion
R– R I I R R – R– R S – –R –
2379 Pseudomonas
Aeruginosa
(Wound swab)
SR R R S R R R RR S R R S – R
2444 Pseudomonas
Aeruginosa
(semen)
S– R R R R R – R– R R – – R –
2378 Escherichia
Coli (urine)
SR R S S R R S I R R R I S – R
2401 Staphylococcus
aureus (Urine)
SR R S S R R S I R R R I S – R
2384 Klebsiella
Pneumoniae
(Pus from
abdominal
wound)
SR R R R R R R RR R R R I– R
2381 Staphylococcus
aureus
(Urine)
S– R S S R S – S– S S – S S –
2445 Staphylococcus
aureus
(urine)
R– R R R R R – R– R R – –R –
2447 Staphylococcus
aureus
(urine)
SS S S S S S S SS S S S S – S
S, Sensitive; R, Resistance; I, Insensitive. (i) Aminoglycosides (1. Amikacin, 2. Netromycin.) (ii) Cephalosporins (1. Cefotoxime, 2. Cefatazidime, 3. Cefuroxime, 4. Ceftriaxone, 5. Cefaparazone.) (iii)
Quinolones (1. Ciprofloxacin, 2. Norfloxacin, 3. Ofloxacin, 4. Levofloxacin) (iv) Sulphamethoxazole with trimetropim (Bactrim) (v) Clavulanic acid with amoxicillin (Augmetin) (vi) Penicillin (Piperacillin)
(vii) Furadentin (Nitrofuran).
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Antimicrobial activity
Effectiveness of Extracts
In general, the aqueous and ethanolic extracts of
Triphala and Triphala Mashi exhibited a broad-spectrum
antimicrobial activity against all the microorganisms
from human secretions and from pathology lab with
prior diagnosis. It inhibited the growth of all Gram-
positive and Gram-negative bacteria. In agar diffusion
method, with the broad range of concentrations of
50–1500mg/ml of the extract, the growth of all
microorganisms was inhibited. Aqueous extracts shows
better activity than ethanolic extract for all strains. More
inhibitory zone is observed for the strains E. coli, S.
aureus. All extracts show dose-dependant activity (Fig. 1).
All the microorganisms that presented resistance to
certain tested antibiotics, showed good susceptibility to
the extracts of Triphala and Triphala Mashi. Variations
of susceptibilities and resistance existed among same
microorganisms to the same antibiotics.
Toxicity Study
No signs of toxicity were observed in short-term analysis
but mortality was seen in long-term study at the dose of
5000mg/kg. The data collected for individual animals is
presented in Table 4. Triphala aqueous and alcohol
extract (50–1500mg/ml)/Triphala Mashi aqueous and
alcohol extract (50–1500mg/ml). Escherichia coli (2443/
2378/2381)/Klebsiella (2438/2384)/Pseudomas (2379/
2444)/Staphylococcus aureus (2401/2445/2447).
Discussion
The antimicrobial mechanisms of tannins can be sum-
marized as follows (21). (i) The astringent property of the
tannin may induce complexing with enzymes or sub-
strates (22). Many microbial enzymes in raw culture
filtrates or in purified forms are inhibited when mixed
with tannins (23). (ii) Tannins toxicity may be related to
their action on membranes of the microorganisms.
(iii) Complexation of metal ions by tannins may account
for tannin toxicity (24). The ester linkage between gallic
acid and glucose was important to the antimicrobial
potential of these compounds.
Some of the simplest bioactive phytochemicals consist
of a single substituted phenolic ring. Catechol and
pyrogallol both are hydroxylated phenols, shown to be
toxic to microorganisms. Catechol has two 2OH groups,
and pyrogallol has three. The site(s) and number of
hydroxyl groups on and the phenol group are thought to
be related to their relative toxicity to microorganisms,
with evidence that increased hydroxylation results in
increased toxicity. In addition, some authors have found
that more highly oxidized phenols are more inhibitory.
The mechanisms thought to be responsible for phenolic
toxicity to microorganisms include enzyme inhibition by
the oxidized compounds, possibly through reaction with
sulfhydryl groups or through more non-specific interac-
tions with the proteins (25).
Several studies have shown that purified catechin
fractions from green and black tea, and Epicatechin
gallate (ECG) and Epigallocatechin gallate (EGCG) in
particular, inhibit the growth of many bacterial species
and possess anticariogenic properties (26–29). ECG and
EGCG, but not Epicatechin (EC) or EGC, have been
reported to be powerful antagonists of human immuno-
deficiency virus reverse transcriptase, causing 50%
inhibition at concentrations of 10–20ng/ml (30). Ikigai
et al. (31) showed that EC was much less active
than EGCG. Staphylococcus aureus was more susceptible
than E. coli, consistent with a much greater binding
of EGCG to staphylococci. The MICs of EGCG and
EC were 73 and 573mg/ml, for S. aureus and 183 and
1140mg/ml, for E. coli, respectively. The bactericidal
effect of EGCG was attributed to membrane
perturbation.
Table 3. Preliminary phytochemical screening
Chemical test Triphala
aqueous
Triphala
Mashi aqueous
Triphala
alcoholic
Triphala
Mashi
alcoholic
Alkloids      
Anthraquinone
glycosides
þ  þ 
Saponins þþ þ    
Steroids and
triterpenoids
     
Phenolic compounds
Tannins
þþ þþ þþ þþ
Proteins      
Ascorbic acid þþ þþ
Sugars      
 , Negative; þ, Positive; þþ, Positive.
Table 4. Effect of Triphala and Triphala Mashi on mortality in Swiss
albino mice
Sr.No. Animal
ID (n¼6)
Dose
(mg/kg)
Short-term
result
Long-term
result
1 H 175 O O
2 B 550 O O
3 T 1750 O O
4 HB 5000 O X
5 BT 5000 O X
6 HBT 5000 O X
X, Died; O, Survived.
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for its antimicrobial effect. To justify the claims made in
Ayurveda, its antimicrobial activity was checked and results
were expressed in terms of zone of inhibition (in cm).
Bacterial strains were multiple drug resistance strains of
both Gram-positive and Gram-negative (Table 2). Both
aqueous and alcoholic extracts of Triphala and Triphala
Mashi were used for antimicrobial activity. Different
concentrations of samples from 50mg/ml to 1500mg/ml
showed linear activity with increase in concentration. Total
organic carbon content was determined to analyse the
organic constituent’s degradation in Triphala Mashi.
Preliminary phytochemical screening of both Triphala
and Triphala Mashi indicates the presence of tannins and
ascorbic acid. Anthraquinone glycosides were present only
in Triphala extract but these are absent in Triphala Mashi
(Table 3). This shows that the degradation of anthraqui-
nones takes place as temperature increases.
Estimation of total phenolic content and total tannins
give reproducible quantity of tannins and phenolics in
both Triphala and Triphala Mashi. TLC study also
reveals that Triphala Mashi contains comparable gallic
acid, ellagic acid and other tannins as that of Triphala. In
the present circumstances antimicrobial effect may be
attributed to these constituents. Further detail analysis is
required in order to confirm the prediction. Also during
TLC research there are new bands formed in Triphala
Mashi which are not present in Triphala that may be due
to heat treatment. So further fractionating and studying
antimicrobial effect is necessary to possibly reveal
molecules from Triphala Mashi. There is need to pursue
the characterization of active principles, to optimize the
observed activity.
Such results are interesting, because bacteria was
isolated from a hospital environment and its control is
difficult by the usual therapeutic means. Studies regard-
ing the mode of action for these compounds in the
bacterial cell should be done.
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